Genetic polymorphism analysis of NAD(P)H: quinone oxidoreductase 1 in different Iranian ethnic groups

Current Science

Volumn 91, Issue 8, 2006, Pages 1065-1068

  Biramijamal, Firouzeh ^a   Sanati, Mohammed Hossein ^a   Banoei, Mohammed Mahdi ^a   Bayat, Behnaz ^a   Arjmand, Sareh ^a   Farhud, Daryoush ^a  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

Author keywords

Ethic groups; Iran; NQO1; Polymorphism

Indexed keywords

EID: 33751014055     PISSN: 00113891     EISSN: 00113891     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Smith, M. T. et al., Low NAD(P)H: quinine oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults. Blood, 2001, 97, 1422-1426.
2. 609C→T polymorphism with a decreased lung cancer risk. Cancer Res., 1999, 59, 3045-3048.
3. Naoe, T. et al., Analysis of genetic polymorphism in NQO1, GSTM1, GST-T1 and CYP3A4 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin. Cancer Res., 2000, 6, 4091-4095.
4. Kawase, H., Hamajima, N., Tamakohi, A., Wakai, K., Saito, T. and Tajima, K., Triplex polymerase chain reaction with confronting two-pair primers (PCR-CTPP) for NQO1 C609T, GSTM1 and GSTT1 polymorphisms: a convenient genotyping method. Asia Pac. J. Cancer Pre., 2003, 4, 67-70.
5. Zhang, J. H. et al., NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J. Gastroenterol., 2003, 9, 1390-1393.
6. Nebert, D. W., Roe, A. M., Vandale, S. E., Bingham, E. and Oakley, G. G., NAD(P)H: quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease. Genet. Med., 2002, 4, 62-70.
7. Moran, J. L., Siegel, D. and Ross, D., A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H: quinine oxidoreductase 1 (NQO1) to benzene toxicity. Proc. Natl. Acad. Sci. USA, 1999, 96, 8150-8155.
8. 609C→T polymorphism in the NAD(P)H: quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood, 1999, 94, 803-807.
9. Ozawa, S. et al., Analysis of bronchial bulky DNA adduct levels and CYP2C9, GST-P1 and NQO1 genotypes in a Hungarian study population with pulmonary disease. Carcinogenesis, 1999, 20, 991-995.
10. Kelsey, K. T. et al., Ethnic variation in the prevalence of a common NAD(P)H quinine oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br. J. Cancer, 1997, 76, 852-854.
11. Wikipedia, the free encyclopedia, http://en.wikipedia.org/
12. 609C→T polymorphism by simple PCR method. Iranian J. Biotechnol., 2004, 2, 203-206.
13. Hamajima, N. et al., NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int. J. Clin. Oncol., 2002, 7, 103-108.